Download Read more here - Wiley Open Access

CTS Open Access Re-launch in 2016
Wiley as the publisher and owner of CTS took steps earlier this year to transfer
ownership and editorial control of the journal to the American Society for Clinical
Pharmacology & Therapeutics (ASCPT). Under the new arrangements, ASCPT
has selected an Editor-in-Chief and editorial team that will take on all editorial
responsibility for CTS, effective with the first 2016 issue.
CTS will publish as an online-only, open access publication. The fully open access
format of the journal, supported by an Article Processing Charge, means that all
articles will be made freely available for all to read immediately upon publication.
In addition, articles will publish under the Creative Commons License, enabling
readers to download the article and share it with others. This platform will allow
for and encourage open discourse on published works.
The CTS submission site is now open and the journal welcomes submission of
high-quality, scientifically sound original research papers focused on clinical
pharmacology and translational science, including animal, in vitro, in silico, and
clinical studies supporting the breadth of drug discovery, development, regulation
and clinical use of drugs. Topics of interest include:
•
•
•
•
•
•
•
•
•
Precision medicine
Translational medicine, including studies focused on Interrogation/evaluation
of mechanism-of-action, human physiology, and interruption of disease
pathophysiology
Hypothesis generating non-clinical and clinical studies, including small clinical
trials
Models of human disease and their therapeutic implications
Studies that guide Phase 2 dose selection
Studies that identify or support biomarkers that can be used at any stage of
drug development
Studies that demonstrate effective communication between basic and clinical
science
Regulatory and public health policy implications of translational studies
PK/PD and quantitative pharmacology as these relate to translational medicine
ASCPT has established the editorial leadership of CTS, to be led by John A.
Wagner, MD, PhD, as Editor-in-Chief, and comprised of leading experts in the
field, to assist in selecting content to be published in the journal as of January
2016.
For authors with articles currently pending peer review, Wiley is committed to
publishing all papers accepted through the end of October before the end of 2015,
and so authors will see their work published under the current journal structure.
From October 1, new submissions will go to the ASCPT team, headed by Dr.
Wagner.
Additional details related to the transition and the ASCPT’s vision for the new
CTS can be found at http://www.ascpt.org/CTS. These include:
•
•
•
•
•
More information on the background and selection of John Wagner, MD, PhD
as Editor-in-Chief
Details on the editorial team that Dr. Wagner has assembled
Details on how authors can submit to the journal and become a reviewer for the
journal
A comprehensive FAQ section for those interested in finding out more about
the re-launch
The updated Aims and Scope and Author Submission Guidelines
If you have a question about your existing CTS submission made prior to the
launch of the new submission site on September 1, please contact Marianne
LaRussa at the existing editorial office at [email protected].
If you would like to submit a new manuscript for consideration in the re-launch of
the journal, please visit the new submission site by clicking here. If you have any
questions about new submissions or general inquiries about the re-launch of the
journal, please contact the editorial office at [email protected].